30 April 1999
HCV genotypes in children and young adults with chronic viral hepatitis C in self-selected material
Anna Szaflarska-Szczepanik, Mieczysława Czerwionka-Szaflarska, Andrzej ChrobotMed Sci Monit 1999; 5(3): CR514-518 :: ID: 504911
Abstract
Data concerning the occurrence of particular HCV types and subtypes in Poland are incomplete and refer mainly to adult patients. The aim of this work was to analyse HCV genotypes in children and young adults with chronic hepatitis. The study was conducted on 54 patients (27 boys and 27 girls) aged 3-20 years, suffering from chronic hepatitis C diagnosed on the basis of serological investigations (over 6-month presence of anti HCV-test UBI, LIATEK and HCV-RNA with the use of RT-PCR method) as well as histopathological evaluation of liver bioptates (according to modified Scheuer classification). HCV genotypes were investigated with the use of Line Probe Assay (INNO - Lipa HCV, Innogenetics) and systematised according to Simmonds classification. Analysis of the frequency of certain HCV genotypes revealed the presence of 1b subtype in 29 patients (53.7%), 1a subtype - in 9 (16.7%), 1 - in 1 (1.8%), 3a - in 3 (5.6%) and 4 - in 12 (22.2%) patients. Mean AlAT activity was 89.6 U/l in subjects with 1a genotype, 68 U/l - in those with 1b, 64 U/L - in patients with genotype 1.43 U/l - in patients with genotype 3a, and 78 U/l - in those with genotype 4. In histopathological picture, trace or slight lesions prevailed, while inflammatory activity of moderate intensification was observed in 14 patients (28%) with various HCV genotypes in a similar percentage of cases. No features of fibrosis were found in the majority of patients, irrespective of HCV type. Type 1 is a dominant genotype in the population of children and young adults with chronic hepatitis C, while clinical picture and the advancement of histopathological lesions in the liver are similar in patients with different genotypes.
Keywords: children and young adults, chronic hepatitis C, HCV genotype
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952